Here's Why You Should Retain Chemed (CHE) Stock for Now

Published on January 19, 2022

Investors are optimistic about Chemed (CHE), given impressive performance of the Roto-Rooter arm and solid growth in VITAS admissions.

Continue reading on website
Other news

Factors Likely to Decide Boot Barn's (BOOT) Fate in Q3 Earnings

January 19, 2022
Boot Barn's (BOOT) third-quarter results are likely to reflect solid omni-channel initiatives, strength in brands and merchandising strategies, and ongoing customer growth.

DaVita's (DVA) New Buyout to Enhance Transplant Experience

January 19, 2022
DaVita (DVA) acquires MedSleuth which will help simplify the kidney transplant process and provide patients greater access to transplantation.